Figure 5
From: Identification of NCAM that interacts with the PHE-CoV spike protein
Anti-NCAM antibody inhibition of PHE-CoV binding to N2a cells. PHE-CoV binding assay using various concentrations of anti-NCAM antibody. The 10 μg/ml anti-NCAM antibody inhibited PHE-CoV binding to N2a cells by 75%. With the increased anti-NCAM antibody concentration in the blocking, the inhibition rate increased accordingly. The 25 μg/ml anti-NCAM antibody inhibited PHE-CoV binding to N2a cells by 95.7%. However, the proliferation of virus could not be suppressed completely.